China Resources Boya Bio-pharmaceutical Group , Ltd. PEG Ratio

China Resources Boya Bio-pharmaceutical Group , Ltd.'s peg ratio stands at 153.22. That is above the Healthcare sector average of 0.46. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

China Resources Boya Bio-pharmaceutical Group , Ltd. sits higher the Healthcare benchmark (0.46) with a PEG ratio of 153.22. That is roughly 32951.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 153.22 is attractive depends on China Resources Boya Bio-pharmaceutical Group , Ltd.'s earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how China Resources Boya Bio-pharmaceutical Group , Ltd.'s PEG ratio evolved across reporting periods, while the comparison chart places 300294.SZ next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. China Resources Boya Bio-pharmaceutical Group , Ltd.'s reading of 153.22 (sector avg 0.46) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.